Raymond James & Associates’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,474
Closed -$379K 3888
2023
Q1
$379K Buy
+10,474
New +$379K ﹤0.01% 3062
2021
Q3
Sell
-9,755
Closed -$300K 4041
2021
Q2
$300K Sell
9,755
-4,281
-31% -$132K ﹤0.01% 3414
2021
Q1
$367K Sell
14,036
-6,157
-30% -$161K ﹤0.01% 3208
2020
Q4
$508K Sell
20,193
-274
-1% -$6.89K ﹤0.01% 2784
2020
Q3
$427K Buy
20,467
+2,140
+12% +$44.6K ﹤0.01% 2733
2020
Q2
$435K Sell
18,327
-5,862
-24% -$139K ﹤0.01% 2671
2020
Q1
$435K Buy
24,189
+706
+3% +$12.7K ﹤0.01% 2501
2019
Q4
$557K Sell
23,483
-27,926
-54% -$662K ﹤0.01% 2635
2019
Q3
$1.41M Buy
51,409
+5,666
+12% +$156K ﹤0.01% 1974
2019
Q2
$1.51M Buy
45,743
+2,271
+5% +$75.2K ﹤0.01% 1958
2019
Q1
$1.52M Sell
43,472
-2,562
-6% -$89.8K ﹤0.01% 1943
2018
Q4
$1.53M Buy
46,034
+36,942
+406% +$1.23M ﹤0.01% 1821
2018
Q3
$458K Sell
9,092
-1,227
-12% -$61.8K ﹤0.01% 2756
2018
Q2
$618K Buy
10,319
+1,557
+18% +$93.2K ﹤0.01% 2532
2018
Q1
$401K Buy
8,762
+1,570
+22% +$71.9K ﹤0.01% 2695
2017
Q4
$287K Sell
7,192
-2,262
-24% -$90.3K ﹤0.01% 2849
2017
Q3
$378K Buy
9,454
+1,396
+17% +$55.8K ﹤0.01% 2631
2017
Q2
$347K Buy
8,058
+151
+2% +$6.5K ﹤0.01% 2625
2017
Q1
$247K Sell
7,907
-17,210
-69% -$538K ﹤0.01% 2798
2016
Q4
$634K Buy
25,117
+3,823
+18% +$96.5K ﹤0.01% 2185
2016
Q3
$527K Buy
21,294
+270
+1% +$6.68K ﹤0.01% 2247
2016
Q2
$428K Sell
21,024
-5,487
-21% -$112K ﹤0.01% 2183
2016
Q1
$404K Buy
26,511
+11,312
+74% +$172K ﹤0.01% 2161
2015
Q4
$204K Sell
15,199
-25,042
-62% -$336K ﹤0.01% 2318
2015
Q3
$565K Buy
+40,241
New +$565K ﹤0.01% 1873